107 13F filers hold it · +8 against the quarter before · shares held +17.8%
Holdings of 06/30
Stocks
All tracked funds
All 5% stake reports on Korro Bio
Korro Bio KRRO
Health care sectorNasdaq
What to see in Korro Bio now
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Fiscal year end
- 12/31
- Next earnings
- 11/05, estimated
- 107 13F filers hold it · +8 against the quarter before · shares held +17.8%Holdings of 06/30
- Atlas Venture Fund XI holds 4.9%Filed 08/04
Funds
13F filers: 107 · +8 since the quarter before · 06/30 holdings
Famous funds that held Korro Bio in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsKorro Bio KRRO · 06/30 holdings | $67.6K | No quarter before |
5% stakes
| Holder | ||
|---|---|---|
| Atlas Venture Fund XI08/04 | 4.9%706,556 sh | No earlier report |
| BlackRock07/29 | 5.2%747,546 sh | First report |
| Point72 Asset Management05/15 | 1.9%276,831 sh | −3.8pp |
| Lynx1 Capital Management04/02 | 10.7%1,538,296 sh | +2.9pp |
| Vanguard Group03/27 | 0%0 sh | −5.2pp |
| Venrock Healthcare Capital Partners III03/17 | 9.9%1,488,685 sh | First report |
| New Enterprise Associates 1703/12 | 9.9%1,456,677 sh | No earlier report |
| Point72 Asset Management03/11 | 5.7%816,885 sh | +2.8pp |
| Point72 Asset Management02/17 | 2.9%276,831 sh | −5.8pp |
| Driehaus Capital Management02/17 | 0%0 sh | −7.2pp |
| Nantahala Capital Management02/13 | 6.37%600,000 sh | First report |
| Vanguard Group01/30 | 5.19%489,639 sh | First report |
| Lynx1 Capital Management01/05 | 7.8%733,633 sh | First report |
| Driehaus Capital Management25/11/14 | 7.16%671,981 sh | +1.9pp |
| Alliancebernstein25/08/13 | 0.1%7,700 sh | −7.4pp |
| Driehaus Capital Management25/02/14 | 5.28%494,905 sh | First report |
| Alliancebernstein25/02/05 | 7.5%705,794 sh | First report |
